Opendata, web and dolomites

Predictix Antidepres

a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report with statistical analysis on the efficacy of antidepressants and their side effects

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Predictix Antidepres project word cloud

Explore the words cloud of the Predictix Antidepres project. It provides you a very rough idea of what is the project "Predictix Antidepres" about.

mission    central    health    vision    clinical    ip    personalised    learning    disorders    ec    genetic    genetics    noted    financial    sequencing    tool    requested    worldwide    action    too    perfectly    organization    measured    framework    benefits    treatments    technologies    plans    dekel    economic    personalized    strategy    vital    founded    house    date    services    remission    oren    disease    suffering    public    accurate    takes    patient    depression    decision    unfair    world    adhd    international    machine    dr    receives    sme    solution    commercialisation    practitioners    fits    optimized    made    mental    revenue    barriers    quality    finalisation    standard    medicine    criteria    nervous    burden    anxiety    care    proprietary    trade    prevalence    solutions    science    patients    2012    disability    fastest    data    predictix    fast    push    instrument    recognizes    efficiency    advantage    treatment    taliaz    platform    advancements    personal    fairness    medical    life    expertise    accessed   

Project "Predictix Antidepres" data sheet

The following table provides information about the project.

Coordinator
TALIAZ LTD 

Organization address
address: 2 PROF. YEHEZKEL KAUFMANN STREET TEXTILE CENTER, 15TH FLOOR
city: TEL-AVIV
postcode: 6801294
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.taliazhealth.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2019-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TALIAZ LTD IL (TEL-AVIV) coordinator 50˙000.00

Map

 Project objective

The World Health Organization recognizes mental disorders as one of the most significant public health challenges worldwide as measured by prevalence, burden of disease and disability , and depression as the world’s leading cause of disability. In EC and WHO action plans it is clearly requested that mental health services can be accessed without unfair financial barriers and that treatments are made available on criteria of both efficiency and financial fairness. In this framework personalised medicine is the fastest, most economic and optimized solution to the depression treatment problem. Indeed, the current push for a cost effective personalised medicine based on IT solution will also help with the commercialisation of our Predictix platform. The platform will allow medical practitioners to have up-to-date and accurate knowledge on each case and improve the care that patient receives, with an economic revenue too. Our solution allows for better delivery of available treatments – noted as a vital factor for increasing remission. TALIAZ was founded in 2012 by Dr. Dekel Taliaz and Oren Taliaz. Our mission is to set a new standard in personalized medicine improving quality of life for patients suffering from depression. Taliaz takes advantage of in-house expertise in genetics, data science and central nervous system related disease with the advancements in genetic sequencing and machine learning technologies, to develop leading personal medicine proprietary IP solutions for depression. Our future vision is to use Predictix™ also as a decision support tool for common health concerns such as ADHD and Anxiety. The SME Instrument project now perfectly fits our strategy and vision by enabling a fast finalisation of the platform development and by providing us the resources necessary to demonstrate the benefits of Predictix™ through an international clinical study.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICTIX ANTIDEPRES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICTIX ANTIDEPRES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

LiCrete (2018)

LiCrete - Light transmitting composite material for building purposes

Read More